This study aimed to identify novel prognostic macrophage markers in mammary cancer by analyzing the transcriptome of CD206+ versus CD206− macrophages, based on the hypothesis that specific subsets within these two macrophage populations are associated with clinical parameters in breast cancer. Here, MRC1 is linked to breast cancer.